阿司匹林抵抗现象的探讨

[1] Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Patricia AG,Kandice KM,Emilio DP,et al. The American Journal of Cardiology . 2001

[2] Platelet-active drugs:The relationships among dose, effectiveness, and side effeets. Patrono C,Coller B,Dalen JE. et al. Chest . 1998

[3] TP or Not TP: Primary mediators in a close runoff. Pratico D,Cheng Y,Fitz Gerald GA. Arteriosclerosis and Thrombosis . 2000

[4] Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthesis in symptomatic atherosclerotic plague as abasis of prostaglandin E (2)-dependent plaque instability. Cipollone F,Prontera C,Pini B,et al. Circulation . 2001

[5] Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction,stroke, or cardiovascular death in patients at high risk for cardiovascular events. Eikelboom JW,Hirsh J,Weit JI,et al. Circulation . 2002

[1] Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Patricia AG,Kandice KM,Emilio DP,et al. The American Journal of Cardiology . 2001

[2] Platelet-active drugs:The relationships among dose, effectiveness, and side effeets. Patrono C,Coller B,Dalen JE. et al. Chest . 1998

[3] TP or Not TP: Primary mediators in a close runoff. Pratico D,Cheng Y,Fitz Gerald GA. Arteriosclerosis and Thrombosis . 2000

[4] Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthesis in symptomatic atherosclerotic plague as abasis of prostaglandin E (2)-dependent plaque instability. Cipollone F,Prontera C,Pini B,et al. Circulation . 2001

[5] Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction,stroke, or cardiovascular death in patients at high risk for cardiovascular events. Eikelboom JW,Hirsh J,Weit JI,et al. Circulation . 2002